Fabio Giglio

申请预约

专科:

成人血液科和骨髓移植科血液科肿瘤科

职业:

血液科医生

医疗机构:

血液科与骨髓移植科 @ 圣拉斐尔科学研究医院

语言:

申请预约

个人简介

Fabio Giglio医生现任IRCCS圣拉斐尔科学研究医院血液病和骨髓移植科专科医生，由Fabio Ciceri教授指导。

2006年从米兰大学内外科专业毕业后，2012年获得米兰圣拉斐尔生命健康大学血液学专业学位。

2011年至2012年间，Giglio医生担任纽约纪念斯隆凯特琳癌症中心血液科和移植科的访问专科医生。

临床实践中，Giglio医生主要负责住院部血液科患者的护理工作。他在异基因造血干细胞移植方面具有特殊专长。Giglio医生还与几家非政府组织合作，致力于提高发展中国家血液病患者的医疗服务质量。

他是急性淋巴母细胞白血病和阵发性夜间血红蛋白尿患者的病理学指导医生。

Giglio医生特别专注以下临床研究领域：急性淋巴母细胞白血病、异基因造血干细胞移植、阵发性夜间血红蛋白尿和地中海贫血的基因疗法。

他以作者或共同作者的身份在意大利国内外学术期刊上发表了多篇文章。此外，他经常参加意大利国内外行业会议。

您需要预约吗？

联系我们，我们将为您妥善安排。

申请预约

出版物

最新出版物

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Posttransplant Cyclophosphamide.

Front Immunol. 2019 Oct 1;10:2319. doi: 10.3389/fimmu.2019.02319. eCollection 2019.

Greco R, Lorentino F, Nitti R, Lupo Stanghellini MT, Giglio F, Clerici D, Xue E, Lazzari L, Piemontese S, Mastaglio S, Assanelli A, Marktel S, Corti C, Bernardi M, Ciceri F, Peccatori J.

Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial.

Biol Blood Marrow Transplant. 2020 Feb;26(2):316-322. doi: 10.1016/j.bbmt.2019.09.032. Epub 2019 Oct

Peccatori J, Mastaglio S, Giglio F, Greco R, Crocchiolo R, Patriarca F, Forno B, Deola S, Assanelli A, Lupo Stanghellini MT, Marcatti M, Zecca M, Cortelazzo S, Fanin R, Fagioli F, Locatelli F, Ciceri F

GITMO. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).

Biol Blood Marrow Transplant. 2019 Dec;25(12):2388-2397. doi: 10.1016/j.bbmt.2019.07.037. Epub 2019 Aug 7.

G, Parma M, Bruno B, Sora F, Bernasconi P, Saccardi R, Foà R, Sessa M, Bresciani P, Giglio F, Picardi A, Busca A, Sica S, Perruccio K, Zucchetti E, Diral E, Iori AP, Colombo AA, Tringali S, Santarone S, Irrera G, Mancini S, Zallio F, Malagola M, Albano F, Carella AM, Olivieri A, Tecchio C, Dominietto A, Vacca A, Sorasio R, Orciuolo E, Risitano AM, Leotta S, Cortelezzi A, Mammoliti S, Oldani E, Bon

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusiondependent ß-thalassemia.

Nat Med. 2019 Feb;25(2):234-241. doi: 10.1038/s41591-018-0301-6. Epub 2019 Jan 21.

Marktel S, Scaramuzza S, Cicalese MP, Giglio F, Galimberti S, Lidonnici MR, Calbi V, Assanelli A, Bernardo ME, Rossi C, Calabria A, Milani R, Gattillo S, Benedicenti F, Spinozzi G, Aprile A, Bergami A, Casiraghi M, Consiglieri G, Masera N, D'Angelo E, Mirra N, Origa R, Tartaglione I, Perrotta S, Winter R, Coppola M, Viarengo G, Santoleri L, Graziadei G, Gabaldo M, Valsecchi MG, Montini E, Naldini

Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant From the Same Donor With No Immunosuppression but C5 Inhibition.

Transplantation. 2019 Feb;103(2):e48-e51. doi: 10.1097/TP.0000000000002505.

Ardissino G, Cresseri D, Giglio F, Onida F, Iannuzzella F, Tel F, Giussani A, Messa P, Longhi S, Vincenti D, Tedeschi S, Cugno M, Ciceri F

KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

J Clin Oncol. 2017 Jul 10;35(20):2268-2278. doi: 10.1200/JCO.2016.70.7059. Epub 2017 May 18.

Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec JB, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H, Reed EF, Yu N, Vierra-Green C, Haagenson M, Malkki M, Petersdorf EW, Spellman S, Hsu KC.

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.325.

Todisco E, Ciceri F, Boschini C, Giglio F, Bacigalupo A, Patriarca F, Donnini I, Alessandrino EP, Arcese W, Iori AP, Marenco P, Cavattoni I, Chiusolo P, Terruzzi E, Castagna L, Santoro A, Bosi A, Oldani E, Bruno B, Bonifazi F, Rambaldi A.

Sirolimus-based Graft-versus-Host Disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

Leukemia. 2014 Jun 4. doi: 10.1038/leu.2014.180.

Peccatori J, Forcina A, Clerici D, Crocchiolo R, Vago L, Lupo-Stanghellini MT, Noviello M, Messina C, Crotta A, Assanelli A, Marktel S, Olek S, Mastaglio S, Giglio F, Crucitti L, Lorusso A, Guggiari E,Lunghi F, Carrabba M, Tassara M, Battaglia M, Ferraro A, Carbone MA, Oliveira G, Roncarolo MG, Rossini S, Bernardi M, Corti C, Marcatti M, Patriarca F, Zecca M, Locatelli F, Bordignon C, Fleischhauer

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

Blood. 2012 May 17;119(20):4813-5. doi: 10.1182/blood-2012-02-411686

Toffalori C, Cavattoni I, Deola S, Mastaglio S, Giglio F, Mazzi B, Assanelli A, Peccatori J, Bordignon C, Bonini C, Cortelazzo S, Ciceri F, Fleischhauer K, Vago L.

Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non hematological disease.

Leuk Lymphoma. 2009 Jan 5:1-5.

Anastasia A, Giglio F, Mazza R, Sarina B, Todisco E, Bramanti S, Castagna L.

您需要预约吗？

联系我们，我们将为您妥善安排。

申请预约